Smart Drug Delivery Systems Market Report 2026

Smart Drug Delivery Systems Market Overview

• Smart Drug Delivery Systems market size has reached to $15.06 billion in 2025 • Expected to grow to $33.15 billion in 2030 at a compound annual growth rate (CAGR) of 16.5% • Growth Driver: Impact Of Rising Chronic Diseases On Smart Drug Delivery Systems Market • Market Trend: Innovations In On-Body Drug Delivery Systems For Enhanced Patient Care • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Smart Drug Delivery Systems Market?

Smart drug delivery systems refer to advanced technologies designed to improve the efficacy, safety, and targeted delivery of pharmaceutical compounds to specific sites within the body. These systems employ various strategies to control the release of drugs, enhance bioavailability, and minimize side effects. The main types of products in smart drug delivery systems are connected inhalers, connected autoinjectors, connected pen injectors, connected wearable injectors, add-on sensors, and others. Connected inhalers are inhaler-based electronic monitoring systems that record drug usage and may include an assessment of the technique of device use. It can be used for various therapeutic areas, including metabolic disorders, neurological disorders, respiratory disorders, hormonal disorders, and others, by different drug delivery modes such as injectable, inhalation, and oral. And it includes various end users, such as hospitals, clinics, home care, ambulatory care settings, and others.

What Is The Smart Drug Delivery Systems Market Growth Forecast?

The smart drug delivery systems market size is expected to see rapid growth in the next few years. It will grow to $33.15 billion in 2030 at a compound annual growth rate (CAGR) of 16.5%. The growth in the forecast period can be attributed to personalized therapy demand, expansion of biologics usage, digital health integration, regulatory support for combination devices, innovation in nanotechnology. Major trends in the forecast period include integration of AI-controlled dosing, growth of implantable delivery systems, rising demand for targeted drug delivery, adoption of wireless connectivity, expansion of combination drug-device products.

Global Smart Drug Delivery Systems Market Segmentation

1) By Product: Connected Inhalers, Connected Autoinjectors, Connected Pen Injectors, Connected Wearable Injectors, Add-On Sensors, Other Products 2) By Therapeutic Area: Metabolic Disorders, Neurological Disorders, Respiratory Disorders, Hormonal Disorders, Other Therapeutic Areas 3) By Drug Delivery Mode: Injectable, Inhalation, Oral Drug Delivery Systems 4) By End-User: Hospitals, Clinics, Home Care, Ambulatory Care Settings, Other End-Users Subsegments: 1) By Connected Inhalers: Dry Powder Inhalers (DPIs), Metered Dose Inhalers (MDIs) 2) By Connected Autoinjectors: Single-Dose Autoinjectors, Multi-Dose Autoinjectors 3) By Connected Pen Injectors: Insulin Pen Injectors, Biologic Pen Injectors 4) By Connected Wearable Injectors: Insulin Wearable Injectors, Infusion Pump Wearable Injectors 5) By Add-On Sensors: Glucose Monitoring Sensors, Medication Adherence Sensors, Temperature Sensors 6) By Other Products: Smart Syringes, Smart Patches, Smart Implants

What Is The Driver Of The Smart Drug Delivery Systems Market?

The rising prevalence of chronic diseases is expected to propel the growth of the smart drug delivery systems market going forward. Chronic diseases are long-term health conditions that progress slowly over time and often have complex causes. The prevalence of chronic diseases is increasing due to aging populations, environmental influences, and disparities in healthcare access. Smart drug delivery systems offer a promising approach to managing chronic diseases by enhancing medication effectiveness and increasing patient adherence. For instance, in April 2025, according to the Centers for Disease Control and Prevention (CDC), a US-based federal agency. in 2023, approximately 194 million U.S. adults, or 76.4%, reported having at least one chronic condition. The prevalence was 59.5% among young adults, 78.4% among midlife adults, and 93.0% among older adults. Therefore, the rising prevalence of chronic diseases is driving the smart drug delivery systems industry.

Key Players In The Global Smart Drug Delivery Systems Market

Major companies operating in the smart drug delivery systems market are Johnson & Johnson, Abbott Laboratories, Novartis International AG, Medtronic plc, Eli Lilly and Company, Novo Nordisk, Becton Dickinson and Company, Baxter International Inc, Phillips-Medisize Corporation, ResMed Inc, West Pharmaceutical Services Inc, Insulet Corporation, Owen Mumford Ltd, Sonceboz, H&T Presspart Manufacturing Ltd, E3D Elcam Drug Delivery Devices, CeQur Corporation, Ypsomed Holding AG, Nemera, Gerresheimer AG, Haselmeier AG, SHL Medical, Aptar Pharma

Global Smart Drug Delivery Systems Market Trends and Insights

Major companies operating in the Smart Drug Delivery Systems market are focusing on developing innovative solutions such as advanced on-body delivery platforms to improve the administration of injectable therapies, enhance patient convenience, and ensure precise dosing. Advanced on-body delivery platforms are wearable systems that deliver medication automatically and precisely over time, improving convenience, safety, and treatment adherence. For instance, in October 2024, Stevanato Group, an Italy-based pharmaceutical solutions provider, launched a its large-volume Vertiva 10 mL on-body delivery system platform at CPHI Milan. The platform is designed to support high-volume injectable therapies with improved usability, safety, and treatment adherence, addressing the growing demand for patient-centric drug delivery solutions.

What Are Latest Mergers And Acquisitions In The Smart Drug Delivery Systems Market?

In October 2023, Novo Nordisk A/S, a Denmark-based pharmaceutical company, acquired Biocorp Production SA for $164.5 million. This acquisition aims to enhance Novo Nordisk's capabilities in developing innovative connected devices and delivery solutions, such as Mallya, a smart add-on device for pen injectors. Biocorp is a France-based designer and manufacturer of medical devices and drug delivery systems for pharmaceutical companies.

Regional Outlook

North America was the largest region in the smart drug delivery systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Smart Drug Delivery Systems Market?

The smart drug delivery systems market consists of revenues earned by entities by providing services such as personalized drug delivery, targeted treatment, diagnostic integration, remote monitoring, and feedback mechanisms. The market value includes the value of related goods sold by the service provider or included within the service offering. The smart drug delivery systems market also includes sales of products including microfluidic devices, transdermal drug delivery patches, electroceutical devices, and remote-controlled drug delivery devices. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Smart Drug Delivery Systems Market Report 2026?

The smart drug delivery systems market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the smart drug delivery systems industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.